Transcripts ULTS ASA

Actions

ULTI

NO0010851603

Temps réel Oslo Bors Autres places de cotation 11:31:29 10/08/2026			Varia. 5j.	Varia. 1 janv.
22,50 ^NOK	-0,44 %		-2,59 %	+932,11 %

03/03/25	Ultimovacs ASA a changé son symbole boursier de ULTI à ZLNA.	CI
03/03/25	Zelluna Immunotherapy AS a acquis Ultimovacs ASA dans le cadre d'une opération de fusion inversée.	CI

Transcripts

31/01/25	Transcript : Ultimovacs ASA, Q4 2024 Earnings Call, Jan 31, 2025
18/12/24	Transcript : Ultimovacs ASA, Zelluna Immunotherapy AS - M&A Call
06/11/24	Transcript : Ultimovacs ASA, Q3 2024 Earnings Call, Nov 06, 2024
21/08/24	Transcript : Ultimovacs ASA, Q2 2024 Earnings Call, Aug 21, 2024
07/05/24	Transcript : Ultimovacs ASA, Q1 2024 Earnings Call, May 07, 2024
17/04/24	Transcript : Ultimovacs ASA - Special Call
07/03/24	Transcript : Ultimovacs ASA - Special Call
14/02/24	Transcript : Ultimovacs ASA, Q4 2023 Earnings Call, Feb 14, 2024
08/11/23	Transcript : Ultimovacs ASA, Q3 2023 Earnings Call, Nov 08, 2023
31/10/23	Transcript : Ultimovacs ASA - Special Call
22/08/23	Transcript : Ultimovacs ASA, Q2 2023 Earnings Call, Aug 22, 2023
08/06/23	Transcript : Ultimovacs ASA - Special Call
10/05/23	Transcript : Ultimovacs ASA, Q1 2023 Earnings Call, May 10, 2023
16/02/23	Transcript : Ultimovacs ASA, Q4 2022 Earnings Call, Feb 16, 2023
10/11/22	Transcript : Ultimovacs ASA, Q3 2022 Earnings Call, Nov 10, 2022
19/08/22	Transcript : Ultimovacs ASA, Q2 2022 Earnings Call, Aug 19, 2022
12/05/22	Transcript : Ultimovacs ASA, Q1 2022 Earnings Call, May 12, 2022
17/02/22	Transcript : Ultimovacs ASA, Q4 2021 Earnings Call, Feb 17, 2022
11/11/21	Transcript : Ultimovacs ASA, Q3 2021 Earnings Call, Nov 11, 2021
21/10/21	Transcript : Ultimovacs ASA - Special Call
20/08/21	Transcript : Ultimovacs ASA, Q2 2021 Earnings Call, Aug 20, 2021
20/05/21	Transcript : Ultimovacs ASA - Special Call
11/05/21	Transcript : Ultimovacs ASA, Q1 2021 Earnings Call, May 11, 2021
17/02/21	Transcript : Ultimovacs ASA, Q4 2020 Earnings Call, Feb 17, 2021
11/01/21	Transcript : Ultimovacs ASA - Special Call